Cargando…

Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents

BACKGROUND: As there are no large-scale reports of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) mRNA vaccination in patients with nephrotic syndrome using immunosuppressive agents, we conducted the prospective study. METHODS: SARS-CoV-2 mRNA vaccines were administered to patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamei, Koichi, Ogura, Masao, Sato, Mai, Nishi, Kentaro, Shoji, Kensuke, Funaki, Takanori, Ogimi, Chikara, Ito, Shuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340689/ https://www.ncbi.nlm.nih.gov/pubmed/35913562 http://dx.doi.org/10.1007/s00467-022-05633-y

Ejemplares similares

Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents
por: Kamei, Koichi, et al.
Publicado: (2020)

Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy
por: Nishi, Kentaro, et al.
Publicado: (2020)

Influenza virus vaccination in children with nephrotic syndrome: insignificant risk of relapse
por: Ishimori, Shingo, et al.
Publicado: (2020)

Central venous catheter infection-related glomerulonephritis under long-term parenteral nutrition: a report of two cases
por: Okada, Mari, et al.
Publicado: (2016)

Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
por: Nishi, Kentaro, et al.
Publicado: (2022)

Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
por: Nishi, Kentaro, et al.
Publicado: (2022)

Live attenuated vaccines in patients receiving immunosuppressive agents
por: Kamei, Koichi
Publicado: (2023)

Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
por: Ishimori, Shingo, et al.
Publicado: (2022)

Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease
por: Shoji, Kensuke, et al.
Publicado: (2023)

Mycobacterium avium complex peritonitis in a pediatric patient on peritoneal dialysis: A case report
por: Yokota, Shunsuke, et al.
Publicado: (2021)

Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy
por: Sugihara, Koichi, et al.
Publicado: (2022)

1696. Urinary tract infection due to Aerococcus urinae in children
por: Sato, Eri, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics Estimation of Eculizumab in a 2-Year-Old Girl With Atypical Hemolytic Uremic Syndrome: A Case Report With 4-Year Follow-Up
por: Saida, Ken, et al.
Publicado: (2019)

The non-immunosuppressive management of childhood nephrotic syndrome
por: McCaffrey, James, et al.
Publicado: (2015)

An update on COVID-19 in paediatric and young adults with nephrotic syndrome, receiving chronic immunosuppression during the Omicron pandemic
por: Angeletti, Andrea, et al.
Publicado: (2022)

Clinical Criteria for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome: An Exploratory Analysis of Optimal Cut-Off Values for Biomarkers
por: Nakamura, Kensuke, et al.
Publicado: (2022)

Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
por: Iijima, Kazumoto, et al.
Publicado: (2017)

Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
por: Trautmann, Agnes, et al.
Publicado: (2022)

A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: a case report
por: Ishiwa, Sho, et al.
Publicado: (2020)

Disseminated Intravascular Coagulopathy Is Associated with the Outcome of Persistent Inflammation, Immunosuppression and Catabolism Syndrome
por: Nakamura, Kensuke, et al.
Publicado: (2020)

Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients
por: Colliou, Eloïse, et al.
Publicado: (2019)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine
por: Wang, Ying, et al.
Publicado: (2020)

Second-Line Immunosuppressive Treatment of Childhood Nephrotic Syndrome: A Single-Center Experience
por: Kim, J., et al.
Publicado: (2014)

Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan
por: Moorani, Khemchand Netaram, et al.
Publicado: (2019)

Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants
por: Tanzawa, Ayano, et al.
Publicado: (2022)

Immunosuppressive IBD drugs and COVID-19 vaccine immunogenicity
por: Hindson, Jordan
Publicado: (2022)

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
por: Horinouchi, Tomoko, et al.
Publicado: (2018)

Clinical characteristics of pediatric patients with COVID-19 between Omicron era vs. pre-Omicron era
por: Iijima, Hiroyuki, et al.
Publicado: (2022)

Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary?
por: Saida, Ken, et al.
Publicado: (2018)

Immunosuppressive Treatment for Nephrotic Idiopathic Membranous Nephropathy: A Meta-Analysis Based on Chinese Adults
por: Xie, Guoqiang, et al.
Publicado: (2012)

The outcome of rituximab in treating steroid dependent nephrotic syndrome.: Histopathology and immunosuppressive drugs as predicting factors
por: Al Salloum, Abdullah A., et al.
Publicado: (2022)

The value of radiographic findings for the progression of pandemic 2009 influenza A/H1N1 virus infection
por: Funaki, Takanori, et al.
Publicado: (2013)

Immunosuppressive plasma cells impede T cell-dependent immunogenic chemotherapy
por: Shalapour, Shabnam, et al.
Publicado: (2015)

New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review
por: Nakazawa, Eriko, et al.
Publicado: (2021)

Combination Immunosuppressive Therapy for Giant Cell Myocarditis
por: Funaki, Takashi, et al.
Publicado: (2022)

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
por: Zhang, Yuzhuo, et al.
Publicado: (2022)

Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab
por: Plymate, Lisa C., et al.
Publicado: (2021)

Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan
por: Shoji, Kensuke, et al.
Publicado: (2022)

Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
por: Shoji, Kensuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_khrv47k8oi4p9cdebtf8bpc56j